Former Green Bay, New England, and Cleveland football player Joe Andruzzi has just completed the first of a 12-step series of chemotherapy treatments for Burkitt's lymphoma, a form of non-Hodgkins lymphoma.

Andruzzi, married and dad to four children, was released by the Browns on May 2 so he and his family could move to New Jersey. Then last week, Andruzzi began experiencing abdominal pain and other symptoms. He consulted with the Browns' medical staff, underwent a colonoscopy, learned an abnormality was found, and then headed to Dana-Farber Cancer Institute in Boston where he was diagnosed with Burkitt's.

The cure rate for Burkitt's -- a rapidly growing, rare form of cancer that strikes only 100 people in the United States each year -- is about 80 percent if patients receive intensive therapy, according to the National Cancer Institute. The other patient survival factor is the stage of the disease. Andruzzi's stage has not been publicly reported.

Norwegian researchers report that about 68 percent of patients who wish to have children manage to do so after successful treatment of Hodgkin's lymphoma.

The researchers studied both men and women survivors. They found that the type of treatment was significantly associated with successful parenthood. The highest probability was in patients treated with radiation only or with less damaging types of chemotherapy.

Dr. Kiserud told Reuters Health, "Information on fertility issues is important in clinical oncological practice, and fertility saving tasks should be discussed with patients at risk of post-treatment infertility. Females should be informed that both the treatment and their age at treatment influence their fertility potential."

Sue Padulo has always been crazy about hockey, but when she had to quit her favourite sport at 26 to undergo intense treatment for her Hodgkin's Disease, she vowed to get back on the ice. But she did more than that ... she started up Puck Cancer, a cleverly-named organization that raises money for cancer and families affected by it through tournaments, the sale of mechandise and more. The women participating in the tournament are pitted against each other, but yet united in their ultimate goal -- shutting out cancer.

Two Puck Cancer tournaments have been held so far, with another one coming up in early August. To find out more about supporting the cause, visit the Puck Cancer website. And, as the ladies at Puck Cancer say, thanks for giving a puck.

I did a post about Alese back in March titled Survival Spotlight: Alese Coco is fighting 2 win. I read on her website today that she passed away on Monday May 7, 2007.

This is what I read on her website.

It is with shattered hearts we announce that Alese died Monday May 7th at 1:20 p.m.

Mentally and emotionally, Alese's attitude to the end remained Fight 2 Win. However, her body could no longer carry on the fight and she succumbed due to respiratory complications. She will be greatly missed and there is a collective ache and void left in the hearts of the many people who loved her and were encouraged by her.

What a beautiful young girl she will be forever.

University of North Carolina football coach Butch Davis recently received a shocking cancer diagnosis after a routine dental visit turned up a suspicious growth in his mouth. Pathology reports identify the cancer as non-Hodgkin's lymphoma.

Davis, 55, has had the growth removed from his gum and while he received his first chemotherapy treatment last week, he's been told there is no indication the cancer has spread to other parts of his body.

Chemotherapy for Davis began at the Cleveland Clinic in Ohio -- Davis coached the National Football League's Cleveland Browns from 2001-2004 -- but will continue at the University of North Carolina Hospital in Chapel Hill.

Davis says he is doing well, that his general health has never been better. And while fighting off cancer, he will work hard at preparing for the 2007 season.

"My family, my health and coaching this football team are my top priorities,'' Davis said. "I would appreciate and expect the focus to remain on the North Carolina football team."

The team opens the season on September 1 against James Madison University.

Those who have been treated for Hodgkin's disease have a 3.6 fold increased risk of heart attack and a 4.9 fold increased risk of congestive heart failure than the general population.

A study was conducted to assess the long-term cardiovascular disease risk in a group of 1474 patients, who survived Hodgkin's lymphoma for at least five years.

Records showed that 28 percent received radiation only; 5 percent had chemotherapy only; 38 percent were treated with radiation and chemotherapy, which did not include anthracyclines, drugs known to damage the heart; and 29 percent received radiation plus chemotherapy with anthracyclines. Of these patients, a total of 84 percent were treated with radiation to the chest.

The study group detected 160 cases of valve disorders, 134 cases of angina, 102 heart attacks and 52 cases of congestive heart failure. Among subjects treated before the age of 20, the risk of angina and congestive heart failure were significantly higher than for those treated when they were older, suggesting that "immature cardiovascular tissue may be more vulnerable to radiation and chemotherapy."

The study team hopes that the outlook for survivors of Hodgkin's lymphoma will brighten over time, as fewer patients are receiving radiation therapy, and when they do, dosages are reduced and patients' hearts are at least partially shielded.

The recommendation for those treated for Hodgkin's is to consider some risk reducing strategies, such as treating high blood pressure and high cholesterol and advising patients to eliminate controllable risk factors.

This post isn't meant to scare anyone diagnosed with Hodgkin's that has been treated with radiation or chemotherapy. I was given an anthracycline as therapy for my breast cancer -- it does linger in the back of my mind that this drug is harmful to the heart and could cause problems later on in my life. I think that those treated for Hodgkin's, especially at a young age when treatments might have been less safe, should think about their lifestyle choices. Talk to your doctor about ways to decrease your risk of these heart problems.

Alese was diagnosed with Hodgkin's disease when she was seventeen years old. This was back in November of 2001 and Alese has been fighting this disease on and off since that time.

After her initial treatment of the standard chemotherapy regimen for Hodgkin's, Alese had her first recurrence after only four months. Alese then received a stem cell transplant in December of 2002 and she was cancer free for two years. On November 18, 2004 it was found that Alese had another recurrence of Hodgkin's.

I have been reading Alese's journal on her blog called Alese Coco Fight 2 Win. She is a courageous young women. You can read her story here, it is very inspirational.

It has been a scary weekend since Alese's family were told that they might have to start making 'end of life' decisions. Alese was having many complications from her disease that it was threatening to take her life. Thankfully, it seems things are looking better this morning. Check out her journal and if you like leave an encouraging message!

Esophagitis is a condition that happens when the esophagus is inflamed and can cause pain and discomfort when swallowing. This is a common side effect when treated with radiation to the chest and neck area and can also be caused by chemotherapy treatments.

Patients receiving radiation for lung cancer, Hodgkin's disease, Non-Hodgkin's lymphoma and head and neck cancer could be at risk for developing esophagitis. After about two weeks receiving the radiation patients might complain of a burning sensation along with pain when swallowing. Usually this condition clears up after a month or so after radiation treatments. When esophagitis occurs with chemotherapy treatments it usually will appear in a few days after treatment.

Some ways to help deal with the symptoms of esophagitis:

• Avoid hot and spicy foods
• Avoid acidic foods such as tomato sauce and orange juice
• drink plenty of cool liquids
• Cold foods are easier to tolerate
• Avoid eggs, ice cream, milk shakes
• Use nutritional supplements to maintain weight
• Ask your doctor about medications to help with esophagitis

Sean Swarner was once given two weeks to live. He is the only person in the world to have ever had two specific types of cancer and he is the longest living survivor of one of them. When he was fourteen he was diagnosed with stage four Hodgkin's Disease. He was expected to live for about three months. A year and a half after chemotherapy he was put in remission only to be stricken the second time with a very aggressive and deadly tumor attacking only three out of a million people. An Askin's disease tumor was attached to his lung and had grown to the size of a golf ball in less than four months. At this point Sean was told that he was only expected to survive for a few weeks.

Sean dreamed of helping others who were in his situation and becoming an incredible inspiration. His goal was to be the first cancer survivor to climb to the top of the earth. Sean achieved his goal in May of 2002 and still strives to climb more mountains. On the summit of Everest Sean brought a flag with names of those affected by cancer and left it at the top of the world forever commemorating the struggle of cancer patients worldwide.

Sean is one of the founding members of The Cancer Climbers Association, a non profit organization dedicated to motivating those afflicted with cancer by encouraging patients to inspire each other. Cancer Climber challenges and facilitates cancer survivors to climb their own Everest, thus overcoming their own limitations and mental boundaries.

Sean has raised cancer awareness and has instilled hope and inspiration in other cancer patients scanning the globe. Along with climbing, Sean now delivers inspirational speeches around the world.

The overall cure rate for the 20,000 children diagnosed with cancer in the United States each year is more than 75 percent. Sounds good -- especially when 50 years ago, most children diagnosed with cancer died. But considering that only one in three childhood cancer survivors remain healthy, perhaps this is not such good news.

Thirty years after diagnosis, about 40 percent of survivors have a serious health problem and one-third have multiple problems. Strokes, heart disease, and kidney failure are just a few of the major health concerns that plague many survivors who have entered adulthood.

Doctors have long known that cancer treatments can cause new cancers later in life. But the Childhood Cancer Survivor Study -- the largest ever childhood study of its kind -- shows there are other long-term health problems. Researchers studied 10,000 survivors -- past studies examined 200-300 survivors -- and found these survivors were eight times as likely as their siblings to develop severe and life-threatening conditions. They found survivors of bone tumors, nerve and brain cancer, and Hodgkin's disease faced the highest risk.

The source of these later-in-life health problems vary. Kidney failure may result from damage caused by chemotherapy or radiation or the infections children suffer when their immune systems are weakened. Drugs used to treat infections may also be to blame. Strokes may result from head and chest radiation.

Cancer treatment for people of all ages comes with a price. We buy time, we buy life in exchange for the unknown. But for children -- who stand to live longer than adults -- there is a greater unknown. Sadly, there is a dark side to surviving cancer.

Ashley was diagnosed with Hodgkin's Lymphoma in 2003. Earlier that year Ashley felt a lump and went to her doctor immediately. She was reassured that it was most likely nothing to worry about. In July she found another lump and her diagnoses was confirmed after returning to the doctor.

The cancer had spread from her neck to her chest, left lung and spleen. Ashley underwent six months of chemotherapy. In March of 2004 Ashley was in remission.

She then dedicated her life to putting together a cancer fundraiser to raise money for lymphoma research. Ashley wanted to give something back.

One week before her Keep on Swimming Gala Ashley was told her cancer had returned. This time the cancer had spread to her neck, chest, lungs, spleen and liver. This development led to Ashley receiving high dose chemotherapy and a stem cell transplant.

Ashley was an amazing girl. I kept up with her blog called Ashley's Journal. I was so sad to hear that she passed away on April 22, 2006. She left a great legacy behind and did so much for such a young girl.

I can't really put into words how brave and admiring she was so I'm going to quote one of her postings on her blog dated February of this year.

"The words palliative and terminal have come up this week. BUT ...they always come with and IF or a WHEN!! These two words are my HOPE. I am still fighting this disease and I haven't give up or surrendered. Yes, these are very scary times but I am also witnessing my bodies amazing ability to heal"

Interferon is an agent that stimulates the immune cells to help fight cancer. In an article published in Bone Marrow Transplantation it said that the addition of interferon following an autologous stem cell transplant improves survival for children with recurrent Hodgkin's lymphoma.

Patients that have their Hodgkin's lymphoma return after initial treatment may undergo an autologous stem cell transplant. In an autologous stem cell transplant a patients own cells are collected prior to high-dose chemotherapy and then re-infused.

The researchers wanted to evaluate whether the addition of interferon to the stem cell transplant could improve outcomes. The trial included 13 children with recurrent Hodgkin's lymphoma who were treated with an autologous stem cell transplant. Ten of these patients then went on to receive the interferon.

Follow up at five years shows that nine of the ten patients treated with interferon are alive and cancer free. The researchers concluded that interferon provided significant anticancer activity following the transplant.